Nvaf quality initiatives. This is a Pfizer-sponsored nonpromotional program. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession. 5 AMA PRA Category 1 CreditsTM. As you can see from the slide, the epidemiology of atrial fibrillation shows a rising prevalence in all groups, but especially in those over the age of 65. Anticoagulation Therapy in NVAF: A Quality Improvement Initiative - Download as a PDF or view online for free This content has been developed for healthcare professionals only. To set the stage for tonight's program, let's take a brief look at the prevalence and impact of AFib in the United States. CME/MOC/NCPD/CPE credit will be available until June 12, 2025. Anticoagulation Therapy in NVAF: A Quality Improvement Initiative The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CE activities must offer fair and balanced content, remain independent of commercial bias, and designed to improve quality in health care. July 26, 2024 The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Speakers have been engaged by Pfizer to share their personal and professional experiences related to population health improvement initiatives within their respective institutions, which may not necessarily reflect the views of Pfizer Sep 5, 2024 · By the end, learners will be able to better recognize the burdens of untreated nonvalvular AF, understand the barriers to optimal use of anticoagulants, and learn strategies to overcome these barriers by implementing their own quality improvement initiatives. Learn about the burden of NVAF and strategies to implement consistent and effective prescribing of DOACs through a quality improvement initiative. . Jul 26, 2024 · Anticoagulation Therapy in NVAF: A Quality Improvement Initiative This activity was designated for 0. Given the challenges facing the selection of anticoagulants in patients with NVAF, we have summarized the differences in mechanism of action between traditional VKAs and DOACs based on a review of recent evidence and clinical use strategies for different individuals. This activity will describe the practical, evidence-based methods that were associated with increasing appropriate anticoagulant utilization in a University of Florida quality improvement initiative. Aug 6, 2025 · The guidelines are intended to support shared decision-making between clinicians and patients, promote quality improvement initiatives, and inform policy and coverage decisions. Patients who seek health information should consult with their physician or relevant patie Learn about the burden of NVAF and strategies to implement consistent and effective prescribing of DOACs through a quality improvement initiative. il7vfe 4n7 ggdg sgdqkjw zep2 ivvsk rg p1 c1t koinq